Reducing Iron Deficiency in 18-36-months-old US Children: Is the Solution Less Calcium?

Elizabeth H Kerling1, Laura M Souther1, Byron J Gajewski2

  • 1Department of Dietetics and Nutrition, University of Kansas Medical Center, MS 4013, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.

Insights

High calcium intake in toddlers may negatively impact iron status, increasing the risk of iron deficiency (ID). Balancing calcium and iron intake is crucial for preventing ID in young children.

Area of Science:

  • Pediatric Nutrition
  • Nutritional Biochemistry

Background:

  • Iron deficiency (ID) is a concern in US children aged 1-3 years, a critical period for brain development.
  • Optimal strategies for recognizing and preventing ID in young children remain debated due to various causes.

Purpose of the Study:

  • To assess iron status in toddlers aged 18-36 months.
  • To identify potential dietary predictors of iron status, focusing on calcium and iron intake.

Main Methods:

  • Assessed iron deficiency biomarkers: soluble transferrin receptor (sTfR) and serum ferritin (SF).
  • Calculated body iron from sTfR and SF.
  • Correlated biomarkers with parent-reported dietary calcium and iron intake in 83 children.

Main Results:

  • 16.9% of children showed indicators of iron deficiency.
  • All children met the Estimated Average Requirement for iron intake.
  • High calcium intake was associated with lower body iron, lower serum ferritin, and higher sTfR.

Conclusions:

  • Iron deficiency rates in the study population were comparable to US national averages.
  • Dietary calcium intake emerged as a stronger predictor of lower iron status than iron intake alone.
  • Educating parents on balancing calcium and iron consumption in toddlers may help prevent iron deficiency.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
720
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
41
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443